Our study indicates that GPM6B suppresses the proliferation and stemness maintenance of glioma through the Integrin β1–β-catenin signaling pathway, although the detailed mechanism of GPM6B interaction with Integrin β1 requires further investigation. The gene discussed is GPM6B; the disease is central nervous system cancer.